A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy
Titel:
A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy
Auteur:
Gralla, R.J. Bosnjak, S.M. Hontsa, A. Balser, C. Rizzi, G. Rossi, G. Borroni, M.E. Jordan, K.